Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bone Biologics Co. stock logo
BBLG
Bone Biologics
$0.82
-2.4%
$0.75
$0.57
$4.25
$2.68M0.531.41 million shs49,230 shs
Cutera, Inc. stock logo
CUTR
Cutera
$0.04
-63.9%
$0.04
$0.09
$2.37
$787K1.362.49 million shs27.70 million shs
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$4.11
-2.8%
$4.25
$2.43
$16.08
$3.61M2.03650,333 shs69,535 shs
Venus Concept Inc. stock logo
VERO
Venus Concept
$2.28
+2.7%
$2.98
$2.10
$17.49
$3.25M-0.03385,271 shs27,503 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bone Biologics Co. stock logo
BBLG
Bone Biologics
-2.38%+13.65%+20.18%-18.81%-46.05%
Cutera, Inc. stock logo
CUTR
Cutera
0.00%0.00%0.00%-90.93%-98.18%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-2.84%-3.75%-40.52%-47.37%-47.43%
Venus Concept Inc. stock logo
VERO
Venus Concept
+2.70%+3.64%-17.09%-33.16%-65.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bone Biologics Co. stock logo
BBLG
Bone Biologics
1.2529 of 5 stars
0.04.00.00.03.40.01.3
Cutera, Inc. stock logo
CUTR
Cutera
1.2305 of 5 stars
3.30.00.00.00.01.70.6
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.0176 of 5 stars
0.02.00.00.00.00.00.0
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bone Biologics Co. stock logo
BBLG
Bone Biologics
0.00
N/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
2.50
Moderate Buy$3.007,592.31% Upside
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.00
N/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bone Biologics Co. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/A$7.42 per shareN/A
Cutera, Inc. stock logo
CUTR
Cutera
$155.21M0.01N/AN/A($8.62) per share0.00
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
$516K6.99N/AN/A$2.44 per share1.68
Venus Concept Inc. stock logo
VERO
Venus Concept
$61.00M0.05N/AN/A($2.43) per share-0.94
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bone Biologics Co. stock logo
BBLG
Bone Biologics
-$8.95MN/A0.00N/AN/AN/A-124.71%-111.64%8/8/2025 (Estimated)
Cutera, Inc. stock logo
CUTR
Cutera
-$162.83M-$6.58N/AN/AN/A-84.86%N/A-45.07%8/6/2025 (Estimated)
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$8.24MN/A0.00N/A-670.95%-201.30%-154.54%N/A
Venus Concept Inc. stock logo
VERO
Venus Concept
-$37.25M-$76.30N/AN/A-74.62%N/A-47.46%8/11/2025 (Estimated)

Latest CUTR, VERO, TIVC, and BBLG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A-$2.52N/A-$2.52N/A$0.07 million
5/15/2025Q1 2025
Venus Concept Inc. stock logo
VERO
Venus Concept
-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 million
5/12/2025Q1 2025
Bone Biologics Co. stock logo
BBLG
Bone Biologics
-$0.48-$0.32+$0.16-$0.32N/AN/A
3/31/2025Q4 2024
Venus Concept Inc. stock logo
VERO
Venus Concept
-$10.0089-$11.23-$1.2211-$11.23$16.99 million$15.77 million
3/21/2025Q4 2024
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
-$85.00-$19.68+$65.32N/A$1.43 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bone Biologics Co. stock logo
BBLG
Bone Biologics
N/AN/AN/AN/AN/A
Cutera, Inc. stock logo
CUTR
Cutera
N/AN/AN/AN/AN/A
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/AN/AN/AN/AN/A
Venus Concept Inc. stock logo
VERO
Venus Concept
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bone Biologics Co. stock logo
BBLG
Bone Biologics
N/A
14.89
14.89
Cutera, Inc. stock logo
CUTR
Cutera
N/A
2.88
1.86
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
N/A
5.65
4.34
Venus Concept Inc. stock logo
VERO
Venus Concept
2.83
1.86
1.18

Institutional Ownership

CompanyInstitutional Ownership
Bone Biologics Co. stock logo
BBLG
Bone Biologics
34.30%
Cutera, Inc. stock logo
CUTR
Cutera
90.70%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
4.25%
Venus Concept Inc. stock logo
VERO
Venus Concept
87.41%

Insider Ownership

CompanyInsider Ownership
Bone Biologics Co. stock logo
BBLG
Bone Biologics
6.10%
Cutera, Inc. stock logo
CUTR
Cutera
0.42%
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
0.31%
Venus Concept Inc. stock logo
VERO
Venus Concept
28.04%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bone Biologics Co. stock logo
BBLG
Bone Biologics
23.27 million2.31 millionNot Optionable
Cutera, Inc. stock logo
CUTR
Cutera
46020.19 million20.10 millionOptionable
Tivic Health Systems, Inc. stock logo
TIVC
Tivic Health Systems
10878,0009.44 millionNot Optionable
Venus Concept Inc. stock logo
VERO
Venus Concept
4101.42 million3.70 millionNot Optionable

Recent News About These Companies

Venus Concept announces $11M debt-to-equity exchange transaction
Venus Concept reports Q4 EPS ($11.23) vs ($20.14) last year

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bone Biologics stock logo

Bone Biologics NASDAQ:BBLG

$0.82 -0.02 (-2.38%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$0.80 -0.01 (-1.83%)
As of 05/23/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

Cutera stock logo

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)
Closing price 03/12/2025
Extended Trading
$0.04 0.00 (0.00%)
As of 03/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Tivic Health Systems stock logo

Tivic Health Systems NASDAQ:TIVC

$4.11 -0.12 (-2.84%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$4.19 +0.08 (+2.04%)
As of 05/23/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Venus Concept stock logo

Venus Concept NASDAQ:VERO

$2.28 +0.06 (+2.70%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$2.27 -0.01 (-0.26%)
As of 05/23/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.